Amount Raised
$30 Million
Round Type
Funding Round
Description
AEON Biopharma, Inc. (“AEON” or the “Company”), a private clinical-stage biopharmaceutical company focused on the development of its proprietary botulinum toxin complex ABP-450 (prabotulinumtoxinA) injection for therapeutic indications, today announced that a group of existing stockholders have invested an additional $30 million into AEON in the form of an unsecured convertible note, bringing the total insider investment into the Company to $54.5 million since December 2021.
Quick answer
AEON Biopharma raised $30 Million in a Funding Round round, dated August 3, 2022. AEON Biopharma is based in Irvine, California, United States.
- How much did AEON Biopharma raise?
- AEON Biopharma raised $30 Million in a Funding Round round on August 3, 2022.
- What does AEON Biopharma do?
- AEON is a clinical stage biopharmaceutical company focused on developing its proprietary botulinum toxin complex, ABP-450 (prabotulinumtoxinA) injection, or ABP-450, for debilitating medical conditions, with an initial..
- Where is AEON Biopharma based and how big is it?
- AEON Biopharma is based in Irvine, California, United States.
- Who are the decision-makers at AEON Biopharma?
- Fundz holds 1 contact at AEON Biopharma. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Healthcare and Therapeutics around the same time
Companies in the same sectors as AEON Biopharma that raised within 45 days of this round, from Fundz verified event records.
- Renibus Therapeutics raised $15M on July 15, 2022.
- SpringWorks raised $225M (Post-IPO Equity) on September 7, 2022.
- Abivax raised $49M (Funding Round) on September 2, 2022.
- LumaBridge raised an undisclosed amount (Private Equity) on August 23, 2022.
- Kymera raised $150M (Post-IPO Equity) on August 19, 2022.
- QurAlis raised $5M on August 12, 2022.
Who to call at AEON Biopharma, and when
A new round usually means AEON Biopharma is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day AEON Biopharma raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at AEON Biopharma, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at AEON Biopharma. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment AEON Biopharma raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
AEON Biopharma raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.